Voyager Therapeutics (VYGR) Receivables - Other (2019 - 2026)
Voyager Therapeutics (VYGR) reported Receivables - Other of $151000.0 for Q1 2026, down 68.99% on a YoY basis from $487000.0 in Q1 2025, and little changed sequentially from $151000.0 in Q4 2025.
Voyager Therapeutics (VYGR) Receivables - Other (2019 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 8 years of Receivables - Other data on file, last reported at $151000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other fell 68.99% year-over-year to $151000.0; the trailing twelve-month figure through Mar 2026 stood at $151000.0 (down 68.99% YoY), and the FY2025 full-year result was $151000.0, down 77.66% from the prior year.
- Receivables - Other held at $151000.0 in Q1 2026, from $151000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $3.7 million in Q3 2024 to a low of $151000.0 in Q2 2022.
- A 5-year average of $1.3 million and a median of $676000.0 in 2024 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other plunged 91.41% in 2022 and soared 2118.54% in 2023, its largest moves.
- Tracing VYGR's Receivables - Other over 5 years: stood at $257000.0 in 2022, then soared by 1200.0% to $3.3 million in 2023, then plunged by 79.77% to $676000.0 in 2024, then plunged by 77.66% to $151000.0 in 2025, then changed by 0.0% to $151000.0 in 2026.
- Business Quant data shows VYGR's Receivables - Other at $151000.0 in Q1 2026, $151000.0 in Q4 2025, and $851000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 151,000.00 |
| Dec 31, 2025 | 151,000.00 |
| Sep 30, 2025 | 851,000.00 |
| Sep 30, 2025 | 851,000.00 |
| Jun 30, 2025 | 851,000.00 |
| Jun 30, 2025 | 851,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Dec 31, 2024 | 676,000.00 |
| Dec 31, 2024 | 676,000.00 |
| Sep 30, 2024 | 3.71 Mn |
| Sep 30, 2024 | 3.71 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 3.34 Mn |
| Dec 31, 2023 | 3.34 Mn |